AI assistant
Sending…
Bionano Genomics, Inc. — Director's Dealing 2023
May 16, 2023
35041_dirs_2023-05-16_28e29830-b732-4ac6-8b92-712b28473ddd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bionano Genomics, Inc. (BNGO)
CIK: 0001411690
Period of Report: 2023-05-12
Reporting Person: OLDAKOWSKI MARK (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-12 | Common Stock | F | 41496 | $0.66 | Disposed | 297842 | Direct |
Footnotes
F1: The reporting person is reporting the withholding by the Issuer of an aggregate of 41,496 shares of common stock that vested on May 12, 2023 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.
More from Bionano Genomics, Inc.
Board/Management Information
2026
Jun 5
Capital/Financing Update
2026
May 28
Declaration of Voting Results & Voting Rights Announcements
2026
May 14
Earnings Release
2026
May 13
Capital/Financing Update
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 2
Share Issue/Capital Change
2026
Mar 25
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18